ATXN7 | Ataxin 7 | Disease related genes Plasma proteins
| | | | | Expressed in all |
AXIN2 | Axin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BAIAP2 | BAI1-associated protein 2 | Plasma proteins
| | | | | Expressed in all |
BBS4 | Bardet-Biedl syndrome 4 | Disease related genes
| | | | | Expressed in all |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
BCAR1 | Breast cancer anti-estrogen resistance 1 | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
BCKDK | Branched chain ketoacid dehydrogenase kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
BDH2 | 3-hydroxybutyrate dehydrogenase, type 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
BIRC2 | Baculoviral IAP repeat containing 2 | Cancer-related genes
| | | | | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BOC | BOC cell adhesion associated, oncogene regulated | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
BPTF | Bromodomain PHD finger transcription factor | Plasma proteins
| | | | | Expressed in all |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
BTN2A2 | Butyrophilin, subfamily 2, member A2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
C12orf10 | Chromosome 12 open reading frame 10 | Predicted secreted proteins
| | | | | Expressed in all |
C12orf66 | Chromosome 12 open reading frame 66 | | | | | | Expressed in all |
C14orf159 | Chromosome 14 open reading frame 159 | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
C16orf93 | Chromosome 16 open reading frame 93 | | | | | | Mixed |
C18orf54 | Chromosome 18 open reading frame 54 | Predicted secreted proteins
| | | | | Tissue enhanced |
C19orf40 | Chromosome 19 open reading frame 40 | | | | | | Mixed |
C19orf47 | Chromosome 19 open reading frame 47 | Predicted secreted proteins
| | | | | Expressed in all |
C19orf80 | Chromosome 19 open reading frame 80 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C1orf159 | Chromosome 1 open reading frame 159 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C1orf198 | Chromosome 1 open reading frame 198 | Predicted secreted proteins
| | | | | Expressed in all |
C1orf56 | Chromosome 1 open reading frame 56 | Predicted secreted proteins
| | | | | Tissue enriched |
C1orf74 | Chromosome 1 open reading frame 74 | | | | | | Mixed |
C21orf33 | Chromosome 21 open reading frame 33 | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
C21orf58 | Chromosome 21 open reading frame 58 | | | | | | Tissue enhanced |
C4orf48 | Chromosome 4 open reading frame 48 | Predicted secreted proteins
| | | | | Mixed |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
C7orf25 | Chromosome 7 open reading frame 25 | | | | | | Mixed |
C7orf43 | Chromosome 7 open reading frame 43 | Predicted secreted proteins
| | | | | Expressed in all |
C9 | Complement component 9 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CADM1 | Cell adhesion molecule 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CALU | Calumenin | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CASC4 | Cancer susceptibility candidate 4 | | | | | | Expressed in all |
CAST | Calpastatin | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CCAR2 | Cell cycle and apoptosis regulator 2 | | | | | | Expressed in all |
CCDC112 | Coiled-coil domain containing 112 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |